Veronica Sanchez Bulis

Insider Reports History

Location
C/O Lyell Immunopharma, Inc., 201 Haskins Way, Suite 101, South San Francisco, CA
Signature
/s/ Mark Meltz, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Veronica Sanchez Bulis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lyell Immunopharma, Inc. VP, Corporate Controller Common Stock 9.21K $148K $16.10 Nov 10, 2025 Direct

Insider Reports Filed by Veronica Sanchez Bulis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LYEL Lyell Immunopharma, Inc. Nov 10, 2025 1 -$3.85K 4 Nov 12, 2025 VP, Corporate Controller
LYEL Lyell Immunopharma, Inc. Oct 31, 2025 0 $0 3 Nov 10, 2025 VP, Corporate Controller